Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
December 1, 2017 Off

STA Pharmaceutical with visible growth in MAH programs in China

By Dino Mustafić

STA Pharmaceutical (STA) – a China-based global API and Drug Product CDMO – reports that it has seen a rapid…

ViiV kicks off third phase of HIV prevention study in women
November 30, 2017 Off

ViiV kicks off third phase of HIV prevention study in women

By Dino Mustafić

ViiV Healthcare on Thursday announced the start of HPTN 084,a phase III study to evaluate long-acting cabotegravir for the prevention of…

Novartis’ Cosentyx shows efficacy in nail and palmoplantar psoriasis
November 30, 2017 Off

Novartis’ Cosentyx shows efficacy in nail and palmoplantar psoriasis

By Dino Mustafić

Novartis has announced first-of-its-kind long-term data showing that Cosentyx (secukinumab) provided sustained improvements in nail and palmoplantar psoriasis out to…

N4 Pharma welcomes having Viagra 50mg as OTC in UK
November 29, 2017 Off

N4 Pharma welcomes having Viagra 50mg as OTC in UK

By Dino Mustafić

N4 Pharma, a specialist pharmaceutical company which reformulates existing drugs and vaccines to improve their performance, welcomes the announcement of the…

Importance of FeNO testing in asthma diagnosis
November 29, 2017 Off

Importance of FeNO testing in asthma diagnosis

By Dino Mustafić

Circassia Pharmaceuticals welcomes the publication of new clinical guidelines by the UK’s National Institute for Health and Care Excellence (NICE),…

Oxford Pharmascience can develop OXPzero Ibuprofen for approval in the US without Phase III trials
November 29, 2017 Off

Oxford Pharmascience can develop OXPzero Ibuprofen for approval in the US without Phase III trials

By Dino Mustafić

Oxford Pharmascience has gotten pre-IND scientific advice from the US regulatory drugs and foods authority about the development programme requirements likely…

Sanofi to ask for updates information on dengue vaccine
November 29, 2017 Off

Sanofi to ask for updates information on dengue vaccine

By Dino Mustafić

Sanofi said on Wednesday it would ask health authorities to update information provided to physicians and patients on its dengue…

TopiVert’s study with consistent effects on dry eye syndrome
November 28, 2017 Off

TopiVert’s study with consistent effects on dry eye syndrome

By Dino Mustafić

TopiVert Pharma, a clinical-stage biotechnology company developing Narrow Spectrum Kinase Inhibitors (NSKIs) for chronic inflammatory gastrointestinal (GI) and ocular diseases,…

EMA OK’s AZ’s Tagrisso variation to the marketing authorisation applicatoin
November 28, 2017 Off

EMA OK’s AZ’s Tagrisso variation to the marketing authorisation applicatoin

By Dino Mustafić

The European Medicines Agency has accepted a variation to the Marketing Authorisation Application (MAAv) for Tagrisso (osimertinib) from Astrazeneca.

OptiBiotix plans to allow the company making future dividend payments
November 28, 2017 Off

OptiBiotix plans to allow the company making future dividend payments

By Dino Mustafić

OptiBiotix Health is planing assemble a General Meeting in which it would ask the shareholders a re-organisation to allow the company to make…

Posts pagination

Previous 1 … 3,423 3,424 3,425 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine